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Abstract
The purpose of this study is to gain insight into the role of BMP signaling in the diversification of the embryonic limb
mesodermal progenitors destined to form cartilage, joints, and tendons. Given the importance of extracellular BMP
modulators in in vivo systems, we performed a systematic search of those expressed in the developing autopod during the
formation of the digits. Here, we monitored the expression of extracellular BMP modulators including: Noggin, Chordin,
Chordin-like 1, Chordin-like 2, Twisted gastrulation, Dan, BMPER, Sost, Sostdc1, Follistatin, Follistatin-like 1, Follistatin-like 5 and
Tolloid. These factors show differential expression domains in cartilage, joints and tendons. Furthermore, they are induced in
specific temporal patterns during the formation of an ectopic extra digit, preceding the appearance of changes that are
identifiable by conventional histology. The analysis of gene regulation, cell proliferation and cell death that are induced by
these factors in high density cultures of digit progenitors provides evidence of functional specialization in the control of
mesodermal differentiation but not in cell proliferation or apoptosis. We further show that the expression of these factors is
differentially controlled by the distinct signaling pathways acting in the developing limb at the stages covered by this study.
In addition, our results provide evidence suggesting that TWISTED GASTRULATION cooperates with CHORDINS, BMPER, and
NOGGIN in the establishment of tendons or cartilage in a fashion that is dependent on the presence or absence of TOLLOID.
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Introduction
In living organisms chondrogenesis occurs in the context of
complex morphogenetic processes associated with the formation of
other connective tissues [1]. The formation of digits in the
developing vertebrate limb illustrates this phenomenon. In the
embryonic limb autopod, mesodermal cells that share a unique
origin from the lateral mesoderm, form phalangeal cartilages and
the associated perichondrium, interphalangeal joints and tendons.
Hence, in terms of tissue differentiation, the formation of a digit,
includes the following: formation of and subsequent differentiation
of prechondrogenic condensations; differentiation of the perichon-
drium; the formation and subsequent differentiation of tendon
blastemas, including the establishment of the entheses (i.e., the
zone where the tendon attaches to the bone primordia); and the
formation of joints (hyaline articular cartilage, synovium, and
fibrous capsule). Different BMP genes exhibit regulated expression
patterns in the undifferentiated and interdigital mesoderm, joints
and tendon blastemas [2,3]. There is compelling evidence that
BMP signaling plays a key role in each of the aforementioned
morphogenetic events [4–11]. However, the mechanism by which
BMPs function to establish divergent cell fates during develop-
mental processes such as chondrogenesis, joint differentiation or
tenogenesis while using the same population of cell progenitors
remains to be clarified [5]. In avian limbs, the overexpression of
BMPs results in a dramatic increase in chondrogenesis [12–14],
and loss-of-function experiments cause severe skeletal truncations
[14]. In mammals, the alterations observed in naturally occurring
or experimentally induced genetic mutations of members of the
BMP signaling pathway, confirmed its role in skeletogenesis
[4,5,7,15–20]. However, digit phenotypes are not very informa-
tive, which is most likely due to the functional redundancy of these
molecules [16,21].
In the canonical signaling pathway, active BMPs are released in
the extracellular space and subsequently bind to transmembrane
type I and type II serine-threonine kinase receptors, triggering an
intracellular cascade that results in the phosphorylation and
nuclear translocation of Smad 1/5/8 proteins, which in conjunc-
tion with Smad 4 and other transcription factors, regulate target
gene expression. In addition, BMPs activate non-Smad pathways
that involve signaling via mitogen-activated protein kinases
(MAPK; see [22]). Taking into account that the signaling cascade
activated by the different BMPs is constant, it is believed that the
differences in the response of BMP target cells may reside largely
on the intensity of the signal. Hence, gradients of BMP signaling
play a key role during vertebrate development to establish the
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dorso-ventral axis of the gastrula, and most likely, function in other
embryonic models [23,24]. The morphogenetic gradient relies
largely on the functional interactions between BMPs and secreted
BMP-binding molecules, often called ‘‘extracellular BMP antag-
onists’’ (see: [25,26]).
Several BMP antagonists are expressed at advanced stages of
limb skeletogenesis [27–29]. In the course of digit development,
Noggin [14], Chordin [30], Chordin-like 1 [31,32], BMPER [33],
Sost [34], Sostdc1 [35,36], Dan [37,38], Follistatin [39,40], and
Follistatin-like 1 [41] have been detected; however, except for
Noggin [4] and Follistatin-like 1 [42], mice that are mutant for
these factors lack a digit phenotype. This lack of a phenotype is
indicative of intense functional redundancy. Therefore, an
appropriate understanding of the role of BMP antagonists in digit
morphogenesis requires a comprehensive analysis of the BMP
modulators that are expressed in the course of digit formation. The
goal of this study was to analyze the involvement of extracellular
modulators of BMP signaling during the early differentiation of the
structural components of the embryonic digits. In an initial
systematic gene expression study we identified 13 different BMP
antagonists with dynamic expression patterns associated with the
differentiation of the phalanges, interphalangeal joints and
tendons. The role of these factors and their regulation by major
signaling pathways that are involved in limb morphogenesis was
next explored through gain-off-function experiments in high-
density cultures of digit mesodermal progenitors. Our findings
provide new insights that clarify the role of BMPs in the divergent
differentiation of the connective tissue progenitors into cartilage,
tendon, and joint tissues, which is a process of major importance in
regenerative medicine of the locomotor apparatus.
Materials and Methods
In this work, we employed Rhode Island chicken embryos from
day 4,5 to day 8 of incubation (id) equivalent to stages 24 to
32 HH. This study was approved by the Cantabria University
Institutional Laboratory Animal Care and Use Committee and
carried out in accordance with the Declaration of Helsinki and the
European Communities Council Directive (86/609/EEC).
In situ Hybridization
In situ hybridization was performed in 100 mm vibratome
sectioned specimens. Samples (a minimum of 5 sectioned limbs of
each stage) were treated with 10 mg/ml of proteinase K for 20
minutes at 20uC. Hybridization with digoxigenin labeled antisense
RNA probes was performed at 68uC. Alkaline phosphatase-
conjugated anti-digoxigenin antibody (dilution 1:2000) was used
(Roche). Reactions were developed with BM Purple AP Substrate
precipitating (Roche). No variability among the samples was
appreciated in the expression pattern of the analyzed genes was
constant in all the samples analyzed.
The probes for Noggin, Chordin (Chd), Chordin-like 1 (Chdl-1;
ventroptin), Chordin-like 2 (Chdl-2); Twisted gastrulation (Tsg; Twsg 1);
DAN (differential screening-selected gene aberrative in neuroblastoma);
BMPER (BMP binding endothelial regulator; crossveinless 2), Sost
(Sclerostin), Sostdc1 (Sclerostin domain containing-1; Uterine sensitization
associated gene-1; Wise; Ectoidin), Follistatin (Fst), Follistatin-like 1 (Fstl-1;
Flick), Follistatin-like 5 (Fstl-5), Tolloid (Tll1; Colloid; Tolloid-like 1)
and Alk1 were obtained by PCR using the following primers: for
Noggin, 59- aaggatggatcattcccagt-39 and 59-ctagcaggagcacttgcact-39;
for Chd, 59-acctgctcttctccatcagc-39 and 59- ccatagtgatgttggcatgg -
39; for Chdl-1, 59-ggaattccgatgagaagaaagtggagatcg-39, and 59-
gctctagagcagattcaccgtgggagtat -39; for Chdl-2, 59- ggcaccactgtgaa-
gatcg -39 and 59- tgtagttctgcgcttcttgc -39; for Tsg, 59- gtcag-
caagtgcctcatcc -39 y 59- cttgcactgatgtattgacatgc -39; for Dan, 59-
tgcgagtccaagtccatcc -39 and 59- ggctcttctacctcctgttgg -39; for
BMPER, 59- aagcgagatgacctgattgg -39 and 59- cgctgaggacatag-
gactgg -39; for Sost, 59- ctctgtctgcgtcctcatcc -39 and 59- taccgagtg-
tagcgcttgc -39; for Sostdc1, 59- ctccgccattcacttctacg -39 and 59-
tgtgctgcctggtgtatcg -39; for Fst, 59- ccgtgtgtggcttagatgg -39 and 59-
gagttgcaagatccagagtgc -39; for Fstl-1, 59- gaatgtgcagtgactgagaagg -
39 and 59- tgagcagcttgttggtctcc -39; for Fstl-5, 59- tcagccactcataa-
gattacgc -39 and 59- tcattggtgtccacaagtcc -39; for Tll1, 59-
gaagatggagcctggagagg -39 and 59- acggaactcaatccacatcc -39; and
for Alk1, 59- agcgactacctggacattgg -39 and 59-ccttcttcatgtcctcgaagc
-39. Chicken probes for Bmpr1a and Bmpr1b were kindly provided
by Lee Niswander and for Alk2 by Joan Massague.
The above mentioned BMP antagonists have been identified in
the genome of most the analyzed vertebrates (Homo sapiens, Pan
troglodytes, Macaca mulatta, Mus musculus, Rattus novergicus, Gallus gallus,
Xenopus laevis) except for the zebrafish (Danio rerio) where there is
only a Chordin-like [43], which is thought to represent Chordin-like 1
and Chordin-like 2 of mammals.
Phospho Smad 1/5/8 and p-c-Jun Immunolabeling
Limb buds between 6 and 8 days of incubation were fixed in
4% PFA O/N at 4uC, washed in PBS and sectioned with a
vibratome. Sections were incubated O/N at 4uC with the primary
antibody. Specimens were next washed in PBS, incubated O/N in
the secondary antibody washed for 2 h in TBS, dehydrated,
cleared and examined with the confocal microscope (LEICA LSM
510). Polyclonal antibodies against phospho-SMAD1/SMAD5/
SMAD8 (Ser463/465; Cell Signaling) and p-c-Jun (Sc-822, Santa
Cruz Biotechnology) were employed. For double labeling purpose,
we employed actin staining using 1% Phalloidin-TRITC (Sigma).
Experimental Induction of Ectopic Digits
In vivo analysis of gene regulation preceding the formation of an
ectopic digit was performed in samples of interdigital tissue 10, 14,
and 20 hr after implantation at 5.5 id of heparin beads (Sigma)
incubated for 1 hr in 2 mgr/ml TGFb1 (R&D Systems). This
treatment leads to the formation of ectopic digits detectable by
alcian blue staining 20 hr or later after bead implantation [44].
The contralateral left limb or limbs treated with beads incubated
in PBS, were employed as controls.
Micromass Mesodermal Cultures
Progenitor mesodermal cells of the digit tissues were obtained
from the progress zone region located under the apical ectodermal
ridge of chick leg buds of embryos at 4.5 id (25 HH). Cells were
dissociated and suspended in medium DMEM (Dulbecco’s
modified Eagle’s medium) with 10% fetal bovine serum, 100
units/ml penicillin and 100 mg/ml streptomycin. Cultures were
made by pipetting 10-ml drops of cell suspension at a density of
2.06107 cells/ml into each well of a 24-well plate. The cells were
left to attach for 2 hr and then 200 ml serum-free medium was
added. In gene overexpression experiments (see below) cultures
were performed with DMEM medium containing 10% fetal
bovine serum and 50 mgr/ml of ascorbic acid. We employed these
cultures for analyzing the effects of adding BMP modulators on
gene regulation, cell proliferation and cell death and to study the
regulation of BMP modulators by major signaling pathways acting
in the autopod.
The effect of BMP modulators and BMP2 were analyzed by
adding recombinant protein to the medium in 24 hr cultures.
Treatments were maintained for another 24 hr period. After
testing different protein concentrations we selected the following:
human recombinant BMP2 200 ngr/ml (Peprotech); human
BMP Antagonists and Connective Tissues
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recombinant NOGGIN, 200 ngr/ml (R&D Systems); human
recombinant CHDL-1, 2400 ngr/ml (R&D Systems); mouse
recombinant CHDL-2 1200 ngr/ml (R & D Systems); human
recombinant TSG 1000 ngr/ml (R & D Systems); mouse
recombinant DAN 3000 ngr/ml (R & D Systems); Follistatin
800 ngr/ml (Peprotech). After these treatments we analyzed by Q-
PCR changes in the expression of cartilage markers (Sox9, type 2
Collagen; and Bmpr1b), fibrogenic markers (Scleraxis, type 1 Collagen
and Tgfb2), and joint markers (Activinba, Gdf5, and Jaws). The
selected genes are well known markers of the corresponding
morpho-developmental processes. Only Jaws has not been used
very often as joint marker, but it has been shown that it is essential
for the formation of interphalangeal joints [45].
To study the effect of autopodial signaling pathways in the
expression of BMP modulators we performed 6 hr treatments to
48 hr Micromass cultures. We employed: FGF2 66 ngr/ml
(Peprotech), ACTIVIN A 200 ngr/ml (Peprotech), all-trans-
retinoic acid (RA) 50 ngr/ml (Sigma); BMP2, 200 ngr/ml
(Peprotech); TGFbeta2, 10 ngr/ml (R&D Systems); and WNT5a
100 ngr/ml (R & D Systems).
Cell Transfections
Gain-of-function experiments for Tsg, and BMPER were
performed by overexpression constructs containing the mouse
coding sequences. We employed ‘‘Addgene plasmid 25778’’ for
Tsg and ‘‘Addgene plasmid 25776’’ for BMPER (both made by
Dr Edward De Robertis). For Fstl-1 overexpression we used a
construct based on the coding sequence of the human gene
cloned into the pCMV6-XL5 vector (Origene, MD, USA). For
Dan overexpression we used a construct based on the coding
sequence of the mouse gene cloned into the pCMV6-ENTRY
vector (Origene, MD, USA) Control samples were transfected
with empty plasmids. Limb mesodermal cells were electropo-
rated employing the Multiporator System (Eppendorf) and
cultured in high-density conditions as indicated above. After
48 hr of cultured the level of gene overexpression and the
expression of cartilage, joint, and tendon markers were
evaluated by Q-PCR.
Flow Cytometry
Cell proliferation and cell death was deduced from measure-
ment of DNA content by flow cytometry in control Micro-
masses and in Micromasses treated with CHDL-1, TSG, or
both CHDL-1 and TSG. For this purpose cultures were
dissociated to single-cell level by treatment with Trypsin EDTA
(Lonza). 1 million cells (5 Micromasses) were used in each test.
For propidium iodide (PI) staining the cells were washed twice
in PBS and centrifuged at 405 g, 5 min at 4uC. The samples
were then incubated overnight at 4uC with 0.1% sodium citrate,
0.01% TritonX-100 and 0.1 mg/ml PI. Cell suspension was
subjected to flow cytometry analysis in a Becton Dickinson
FacsCanto cytometer and analyzed with Cell Quest software.
This technique allows the titration of apoptotic (hipodiploid) and
proliferating (hiperdiploid) cells according to their DNA content
deduced from PI staining [46].
Real time Quantitative PCR (Q-PCR) for Gene Expression
Analysis
In each experiment total RNA was extracted and cleaned from
specimens using the RNeasy Mini Kit (Qiagen). RNA samples
were quantified using a spectrophotometer (Nanodrop Technol-
ogies ND-1000). First-strand cDNA was synthesized by RT-PCR
using random hexamers and M-MulV reverse transcriptase
(Fermentas). The cDNA concentration was measured in a
spectrophotometer (Nanodrop Technologies ND-1000) and ad-
justed to 0.5 mg/ml. Q-PCR was performed using the Mx3005P
system (Agilent) with automation attachment. In this work, we
have used SYBRGreen (Agilent) based Q-PCR. Gapdh had no
significant variation in expression across the sample set and
therefore was chosen as the normalizer in our experiments. Mean
values for fold changes were calculated for each gene. Each value
in this work represents the mean 6 SEM of at least three
independent samples obtained under the same conditions.
Samples consisted of 4 Micromass cultures or 15 interdigital
spaces. Data were analyzed using one-way analysis of variance
followed by Bonferroni tests for post-hoc comparisons or Student’s
t test, for gene expression levels in overexpression experiments.
Statistical significance was set at p,0.05. All the analyses were
done using SPSS for Windows version 18.0. Primers for Q-PCR
are included as Supplementary Table 1.
Results
Extracellular BMP Modulators
In an initial PCR expression screening, we identified 13
different extracelular modulators of BMP signaling that were
expressed at high levels in mesodermal tissues of the developing
chick autopod at day 6 of incubation, including: Noggin, Chordin
(Chd), Chordin-like 1 (Chdl-1; ventroptin), Chordin-like 2 (Chdl-2); Twisted
gastrulation (Tsg; Twsg 1); DAN (differential screening-selected gene
aberrative in neuroblastoma); BMPER (BMP binding endothelial regulator;
Crossveinless 2), Sost (Sclerostin), Sostdc1 (Sclerostin domain containing-1;
Uterine sensitization associated gene-1; Wise; Ectoidin), Follistatin (Fst),
Follistatin-like 1 (Fstl-1; Flick), Follistatin-like 5 (Fstl-5), and Tolloid
(Tll1;Colloid; Tolloid-like 1). Although Tolloid is not a BMP
antagonist but rather is a protease, it was included here because
it is responsible for the release of the BMP ligands that are
bounded to BMP antagonists into the target tissues [26]. Although
the presence of some of these factors was known from previous
Table 1. Regulation of BMP modulators.
10 h 14 h 20 h
Noggin 1,0060,1 1,9360,2** 3,9860,9*
Chd 1,3660,3 1,1160,1 1,2360,4
Chdl-1 3,6461,0* 3,8360,7* 8,0961,7*
Chdl-2 1,9060,2* 2,3360,4* 2,9461,0**
Tsg 1,2760,2 1,2760,4 1,2460,1
Dan 1,0160,0 1,1660,0 3,4060,9*
Bmper 1,3060,1 1,8560,3* 1,8560,2*
Sost 1,0260,2 0,9460,0 1,0060,0
Sostdc1 0,9260,1 1,1360,1 1,1260,0
Follistatin 9,0961,3*** 5,1460,4*** 8,1661,7*
Fstl-1 0,8660,0 1,1560,0 1,1260,0
Fstl-5 0,4760,1* 1,3860,2 0,9960,1
Tll1 1,3360,1 2,5560,6* 2,2360,1**
Regulation of BMP modulators at 10, 14, and 20 hr after interdigital
implantation of a bead bearing TGF-b1. In all experiments an ectopic digit was
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studies, we next performed a systematic study of all of them using
in situ hybridization to demonstrate a complete picture of their
spatial distribution within the developing autopod (Fig. 1). We
excluded the members of the CCN secreted factors and the
members of the HtrA serine proteases from the study because they
have been analyzed in detail elsewhere [44,47].
Noggin and Chdl-1, are prominently expressed in the central
region of the differentiating phalanges, excluding the peripheral
subperichondrial region and the zones of joint formation (Fig. 1 A
and C). Noggin is also expressed in the proximal region of the
tendons at advanced stages of differentiation (Fig. 2A).
Chdl-2, is expressed in the hyaline articular cartilage of mouse
embryonic and in human adult osteoarthritic joints [29]. Here we
found a wide and well-defined expression domain for this BMP
antagonist in the digit blastemas that precede the identification of
interphalangeal joints (Fig. 1D). The expression of Chdl-2 is also
noted in the diaphysis of metatarsals preceding the ossification of
hypertrophic cartilage forming a collar under the perichondrium
(Fig. 2E).
At the beginning of digit formation, Chd is expressed at low
levels in the digit rays (Fig. 1B), with a slight intensification in the
zones of joint formation. Small Chd expression domains are also
prominent in the zone of the tendons located close to the foot
muscles (Fig. 2C). Chd transcripts are also present in the diaphysis
of the digit cartilages preceding the ossification of hypertrophic
cartilage forming a collar under the perichondrium (Fig. 2C).
Tsg is expressed in zones of cartilage and tendon differentiation
(Fig. 1 E and I). In the chondrogenic regions Tsg forms a tenuous
expression domain in the cartilage subjacent to the perichondrium
of the digit rays. This peripheral digit expression domain is
intensified in the digit tip marking the zone of recruitment of
cartilage progenitors, the previously termed, ‘‘digit crescent’’ [48],
Figure 1. In situ hybridizations in longitudinal (A–G, M–P) and transverse (H–L; Q–T) vibratome sections of the autopod showing
the expression of Noggin (A), Chd (B), Chdl-1 (C), Chdl-2 (D), Tsg (E and I), Dan (F and J), BMPER (G and K), Sost (H), Sostdc1 (L), Tll1 (M
and Q), Fst (N and R), Fstl-1 (O and S), and Fstl-5 (P and T). All the specimens are at day 6,5 of incubation (stage 30HH) except H, which is at 7,5
days of incubation (stage 32HH).
doi:10.1371/journal.pone.0060423.g001
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and also in the developing joints. Additionally, its expression is
remarkable in the subectodermal mesenchyme with zones of high
intensity marking the tendon blastemas.
Dan forms a continuous expression domain in the mesenchyme
subjacent to the dorsal and ventral ectoderm with zones of
increased expression marking the tendon blastemas (Fig. 1 F and
J). BMPER is expressed in small but intense domains located in the
most proximal zone of the interdigits and along the lateral margins
of the extensor and flexor tendons (Fig. 1, G and K). It is also
strongly expressed in the lateral margins of the autopod at the
borderline with the zeugopod. BMPER is also expressed in the
diaphysis preceding the ossification of hypertrophic cartilage
forming a collar under the perichondrium (Fig. 2D).
Sost expression has been studied in early stages of limb
development [34]. Here we show that at advanced stages of digit
development, Sost is expressed in the maturing tendons (Fig. 1H)
and in the subperichondral region of the diaphysis, which is
undergoing hypertrophic differentiation (Fig. 2F).
Sostdc1 is expressed mainly in the ectoderm with the highest
transcript levels in the interdigit region (Fig. 1 L). Transcripts are
also observed in the mesenchymal peridigital tissue in a fashion
resembling that of BMPER (Fig. 1L).
Tll1 is expressed in the contour of the immature phalanges,
including the early developing joints and the tip of the digit (Fig. 1,
M and Q). In this distal digit region, the transcripts form a cap
encompassing the condensing mesenchyme. Tll1 transcripts are
also present in the mesoderm subjacent to the dorsal and ventral
ectoderm of the interdigital and digital regions excluding the zone
of tendon formation (Fig. 1Q). However, in the proximal regions
where tendon maturation is advanced, including the zone of
myotendinous junction, tll1 transcripts are also detected in the
tendon tissue (Fig. 2G).
Fst shows restricted expression domains in the tendon blastemas
(Fig. 1 N and R). Fstl-1 is highly expressed in the interdigital
mesoderm with additional domains in the developing joints (Fig. 1
O and S), while Fstl-5, is expressed at low levels in the core of the
differentiating digit cartilages (Fig. 1 P and T). However, in
proximal regions where tendon maturations is advanced, Fstl-5
transcripts are also detected in the tendon tissue and in the
subperichondral region of the diaphysis undergoing hypertrophic
differentiation (Fig. 2B).
Figure 2. In situ hybridization on transverse sections of the proximal segment of the autopod of embryos after 7 and 7,5 days of
incubation, to show the expression domains of BMP modulators in the zone of hypertrophic differentiation of the metatarsal and
in the maturing tendons at the zone close to the myotendinous junction. Noggin (A), Fstl- 5 (B), Chd (C), BMPER (D), Chdl-2 (E), Sost (F), Tll1
(G), and Tsg (H). Note that at this stage of differentiation Tll1 transcripts are present in the tendon blastemas (arrow heads in G). Note also that the
expression domains in the diaphysis of the metatarsal are specifically located in the inner cellular layer of the perichondrium in the interface with the
hypertrophic cartilage.
doi:10.1371/journal.pone.0060423.g002
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BMP Signaling Domains in the Developing Digits
The zones of active BMP signaling were monitored by BMP
effectors immunolabeling (Fig. 3). Active BMP signaling
domains that were marked by phospho-smad 1/5/8 are present
in the interdigital mesenchyme and in the core of the
developing cartilages, with greater intensity in the tip of the
growing digit (Fig. 3 A and D). The perichondrium shows poor
labeling and the interface between the cartilage and the
perichondrium is relatively devoid of signaling (Fig. 3 B). In
the course of digit differentiation, the labeling in the cartilage is
reduced while it increases in the outer layer of the perichon-
drium (Fig. 3C). The tendon formation zones are almost
negative, but are encompassed at both sides by zones of intense
signal in a pattern closely paralleling the expression of BMPER,
including stronger expression in the dorsal than in the ventral
regions of the autopod (compare Fig. 1K and Fig. 3A).
However, a weak positive stain is observed in the tendons at
advanced maturation stages and in the zone of myotendinous
junction (Fig. 3C). As expected from previous studies [22], the
zones of joint formation appear as bands of low phospho-Smad
1/5/8 positivity (Fig. 3D), but exhibit intense labeling by
phospho-c-Jun, which is activated by the JNK MAP kinase
(Fig. 3E).
As shown in Figure 3 (F–M), all the structures of the autopod
exhibited transcripts of at least one of the four type 1 receptors of
this signaling pathway, including Bmpr1b (Alk6), Bmpr1a (Alk3), Alk2
(ACVR1), and Alk1 (ACVRL1; see [49]), supporting the function of
BMP antagonists in the establishment of the zones of active
signaling.
The Expression Sequence of Extracellular Bmp
Modulators during the Formation of an Ectopic Digit
(Table 1)
To gain insight into the significance of BMP modulators during
digit morphogenesis we monitored the temporal sequence of
activation of BMP antagonist genes when an ectopic digit is
induced in the interdigital regions by implantation of a Tgf b bead
[32]. An analysis of expression was performed using Q-PCR at 10,
14 and 20 hr after interdigital implantation of a Tgfb-bead
(Table 1). We selected these time points because 10 hr marks the
stage at which genes encoding for the cartilage matrix become
upregulated, and 20 hr corresponds with the period when the
extra digit condensation become identifiable by specific histolog-
ical dyes (i.e., Alcian Blue; [44]). At this period the connective
tissues located around the ectopic cartilage; including the
perichondrium and the pretendinous aggregates, initiates differ-
entiation. Chdl-1, Chdl-2 and Fst genes were upregulated at 10 hr
after bead implantation, coincident with the upregulation of the
most precocious extracellular matrix markers of cartilage differ-
entiation [44]. By14 hr after bead implantation Noggin, BMPER,
and Tll1 were up-regulated. Dan was the last of the examined BMP
antagonists to be up-regulated during the formation of the ectopic
digit (20 hr after bead implantation), consistent with a function in
the differentiation of tendons. In the period covered by our study,
Tsg appeared moderately upregulated from 10 hr, but without
reaching levels of statistical significance. Fstl-5 was transiently
downregulated at 10 hr after bead implantation. There were no
changes in the expression of Fstl-1, Sost and Sostdc1. Transcripts of
those three genes are present in the interdigital mesoderm from
the beginning of the experiment, and the formation of an ectopic
digit may not generate detectable changes in their levels of
expression.
Gene Regulation after Administration of Extracellular
BMP Modulators
The structure and functional properties of the BMP modulators
are not uniform. Antagonism of BMP signaling may be variable
due to differential affinity for distinct ligands. Hence, to gain
insight about their role in the developing digits, we monitored the
effects on the regulation of most of BMP modulators by the
addition of recombinant proteins to Micromass cultures of digit
progenitors. In some cases, protein-addition based experiments
were complemented or substituted by overexpression approaches,
employing vectors containing the full gene coding region. Several
preliminary experiments were performed to adjust the dose of
BMP regulators to obtain clear and reproducible effects on the
genes explored. Tables 2 to 4 summarize the changes in the
expression of the cartilage (Table 2), joint (Table 3), and tendon
(Table 4) markers selected in this study. The effects of BMP2 on
the expression of the mentioned markers were also analyzed to
allow a clear distinction between effects that were dependent or
independent of the inhibition of BMP signaling (data are shown at
the bottom of each table). The following aspects can be
emphasized from results:
1) The overexpression of the mouse Tsg gene induced down-
regulation of chondrogenic markers (Sox9, Collagen2 a1,
Bmpr1b), Gdf5 and Jaws. In addition, the tenogenic master
gene Tgfb2, which was not regulated by BMP2, was strongly
downregulated following Tsg overexpression.
2) At the highest doses tested (up to 1000 ng/ml) rhTSG, was
much less effective than gene overexpression experiments.
Treatments caused only a mild downregulation of Tgfb2 and
Gdf5. However, the gene regulation that was induced by
CHDL-1, CHDL-2, or NOGGIN was strongly potentiated
when they were administered in combination with rhTSG
(1000 ng/ml). This effect supports the functional association
between TSG and CHD that has been observed in other
systems [50] and supports also the interaction of TSG with
NOGGIN, which to our knowledge, has not been reported
in previous studies. This interplay potentiated the BMP
antagonistic effect of CHDL-1 and NOGGIN, and also
caused modifications in the regulation of genes not induced
by BMP2 (see below), and even regulations not observed in
separate treatments of TSG and CHDL-1, or NOGGIN (i.e.
the regulation of Activin ba in combined treatments with
CHDL1-TSG, Table 3; and see below for interactions
NOGGIN-TSG).
3) NOGGIN, was the most intense antagonist of gene
regulation induced by BMPs in Micromass cultures (see
tables 2–4); however, treatments also induced the upregula-
tion of Scleraxis, type 1 Collagen, and Tgfb2 which are not
regulated by BMP2. As mentioned above, the effects of
NOGGIN were intensified when administered in combina-
tion with TSG. Intensification was appreciated even for the
effects like the up-regulation of Scleraxis, type 1 Collagen, or
Tgfb2 which are not induced by BMP2. In addition,
NOGGIN in combination with TSG down-regulate the
expression of Jaws. A detailed analysis of the molecular bases
for the interplay between TSG and NOGGIN is out of the
scope of this study. However, considering the roles of TSG
in other systems (see discussion for references), a tentative
explanation is that the addition of TSG may protect
sequestering and/or degradation of NOGGIN in the
extracellular matrix.
BMP Antagonists and Connective Tissues
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e60423
4) CHDL-1, was ineffective at doses ranging between 400 and
2500 ng/ml; however, as previously mentioned, CHDL-1 in
combination with rhTSG exhibited BMP antagonism at
remarkable levels.
5) CHDL-2 administered alone (up to 1200 ng/ml), caused a
moderate upregulation of Scleraxis, Tgfb2 and Gdf5 and had
no effect on most chondrogenic markers; however, when
CHDL-2 was administered in combination with rhTSG,
Sox9, type 2 Collagen and Bmpr1b were downregulated.
6) Previous analysis in different systems has provided contro-
versial information concerning the targets of DAN
[38,51,52]. It has been proposed that the production of
bioactive DAN protein is cell-specific [52]. In our analysis
the BMP targets analyzed here were not significantly
Figure 3. Immunolabeling for p-Smad 1/5/8 (green, A–D) and p-c-Jun (green, E), to show the zones of active BMP signaling in the
course of digit formation. Note in A, the absence of labeling in the tendon blastema (tb) at 7,5 days of incubation. In addition, zones of intense
labeling paralleling the expression of BMPER of are observed, (arrows, compared with Fig. 1K). B is a higher magnification image of A to show the
labeling in the differentiating cartilage except in the most peripheral region subjacent to the perichondrium (p). C shows positive labeling in a
proximal region of the tendons corresponding with the myotendinous junction (day 8 of incubation). D is a longitudinal section of digit 3 at day 6 of
incubation showing intense labeling in the growing tip (dt) and reduced labeling in the zones of joint formation (arrow heads). E, is a longitudinal
section of digit 3, showing intense labeling for p-c-Jun in the joint forming region (arrow heads). In A and B the actin cytoskeleton was labeled in red
with Phalloidin-TRITC. F–M, are longitudinal (F, G, I, K, and M) and transverse (H, J, and L) sections through digit 3 showing the expression of type 1
BMP receptors in the autopod. Bmpr1b (F–H) is highly expressed at RNA (F–H) and protein (G) levels in the early chondrogenic digit ray with zones of
reduced expression in the joint forming region. In the non-chondrogenic domains of the autopod, the expression of Bmpr1b is predominant in the
subectodermal mesenchyme and interdigital regions. Expression of Bmpr1a (I–J) and Alk2 (K–L) is poor in the chondrogenic rays, but transcripts are
abundant in the tissues around the digit cartilage including the perichondrium, the interdigital mesenchyme. Transcripts of Alk2, are also appreciated
in the developing joints (arrow in K). Alk 1 was only appreciated in the peridigital blood vessels (M).
doi:10.1371/journal.pone.0060423.g003
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regulated by mouse recombinant DAN even at doses up to
3000 ng/ml. However, overexpression of the mouse Dan
gene down-regulated chondrogenic markers (Sox9, type 2
Collagen, and Bmpr1b) and up-regulated the expression of
Scleraxis more than twofold.
7) BMPER gain-of-function experiments were done by over-
expressing the mouse BMPER gene and the effects on the
chondrogenic markers corresponded largely with those of a
typical BMP antagonist. However, Scleraxis, and Activin ba,
which are not regulated in treatments with BMP2, were also
up-regulated by this factor.
8) FST exhibited an intense inhibitory effect on Sox9 gene
expression, but the expression of other genes up-regulated
by BMPs was not down-regulated. Remarkably, no effects of
FST were recognized in tendon markers in spite of its
restricted expression in the tendon blastemas.
9) The overexpression of Fstl-1 had similar, but less intense,
effects than the addition of rh-NOGGIN, except for a
negative influence in the expression of Activin ba which did
not occur with NOGGIN.
Cell Proliferation and Cell Death in Micromass Cultures
following Treatments with BMP Antagonists
The low anti-BMP influence on gene regulation in rh-CHDL-1
alone treatments prompted us to check whether it has an effect
promoting cell proliferation as reported in cultures of human
mesenchymal stem cells [53]. However, no changes in cell
proliferation or apoptosis were observed in cultures treated with
different doses of CHDL-1 (Fig. supplementary 1).
In view of the functional potentiation of the effects of CHDL-1
when administered in combination with TSG, we further analyzed
the effects of the combined treatments of CHDL-1 and TSG.
Neither cell proliferation or cell death was modified by this
treatment (Fig. supplementary 1).
Table 2. Regulation of Cartilage Markers.
CARTILAGE Sox9 Col2a1 BmpR1b
TSG 0,9960,2 1,0660,1 0,8560,0
TSG o/e 0,3860,0** 0,4660,0* 0,5860,0*
NOGGIN 0,2760,0*** 0,1160,0*** 0,1660,0***
NOGGIN+TSG 0,1460,0** 0,0660,0*** 0,0660,0***
CHRDL1 0,7360,0 0,9660,0 1,0160,0
CHRDL1+ TSG 0,3760,1** 0,4460,0** 0,2360,1**
CHRDL2 0,7760,0 0,8060,0 0,9660,1
CHRDL2+ TSG 0,6260,0* 0,4560,0** 0,4460,0**
DAN 1,0060,1 0,9960,0 0,9660,0
DAN o/e 0,5460,0* 0,4560,0** 0,3560,0**
BMPER o/e 0,5660,0* 0,4560,0* 0,8060,1
FST 0,5860,1*** 1,6760,3* 1,0260,0
FSTL1 o/e 0,3560,0* 0,3960,0* 0,7360,0*
BMP2 5,5860,9* 12,262,6* 4,1560,1*
Regulation of 3 selected markers of cartilage in 2 days Micromass cultures of
digit progenitors treated for 24 hr with recombinant proteins. As indicated in
the table (o/e), in the cases of TSG, DAN, and BMPER gain-of-function






Table 3. Regulation of Joint Markers.
JOINT Gdf5 Activin BA Jaws
TSG 0,7960,0* 0,7960,0 1,2260,1
TSG o/e 0,3960,0** 0,9160,1 0,5760,0*
NOGGIN 2,2360,5* 1,0960,1 1,3860,1
NOGGIN+TSG 1,8260,0** 0,8060,1 0,3360,0**
CHRDL1 1,1660,1 0,9260,0 1,0160,0
CHRDL1+ TSG 0,9960,0 0,4460,0*** 0,8560,1
CHRDL2 1,4160,2* 0,6060,0* 0,9560,1
CHRDL2+ TSG 1,4560,1* 0,8360,1 1,1160,1
DAN 1,2560,0 1,1160,0 0,7860,0
DAN o/e 0,6760,2 1,1860,1 0,9760,2
BMPER o/e 1,0760,1 1,4860,0*** 1,1060,2
FST 1,2860,1 0,9760,1 1,3160,1
FSTL1 o/e 1,3960,0* 0,6360,0* 1,1260,1
BMP2 0,0260,0** 12,0561,2** 1,0760,2
Regulation of 3 selected markers of fibrous and tendon tissue in 2 days
Micromass cultures of digit progenitors treated for 24 hr with recombinant
proteins. As indicated in the table (o/e), in the cases of TSG, DAN and BMPER
gain-of-function experiments were also performed by transfection of





Table 4. Regulation of Tendon Markers.
TENDON Scleraxis Col1a1 Tgfb2
TSG 1,1560,2 1,1260,0 0,7360,0**
TSG o/e 0,8360,0 0,8360,1 0,5260,0***
NOGGIN 1,9860,3* 1,5060,1** 2,9760,4**
NOGGIN+TSG 2,1560,0** 1,7260,1** 4,7960,3**
CHRDL1 0,9960,0 0,9860,0 0,9860,1
CHRDL1+ TSG 0,6060,1 0,9060,1 0,6660,0*
CHRDL2 1,5360,0* 1,1360,1 1,5960,1*
CHRDL2+ TSG 1,8160,3* 1,2060,2 1,2160,2
DAN 1,2860,3 1,0160,0 1,0260,0
DAN o/e 2,6460,6* 0,9460,0 0,8360,0
BMPER o/e 2,3860,2* 1,0860,0 1,3660,2
FST 0,9760,1 1,0560,1 0,9360,1
FSTL1 o/e 1,8160,1** 1,4060,0** 1,4460,0**
BMP2 0,1360,0** 0,6960,0 0,7960,0
Regulation of 3 selected genes responsible for joint formation in 2 days
Micromass cultures of digit progenitors treated for 24 hr with recombinant
proteins. As indicated in the table (o/e), in the cases of TSG, DAN and BMPER
gain-of-function experiments were also performed by transfection of
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Transcriptional Regulation of BMP Modulators by Major
Signaling Pathways Operating in the Developing
Autopod
To the light of the regulated expression patterns of BMP
antagonists and their distinct effects on mesodermal tissue
differentiation, we sought to known if, as reported in other models
[54], there is an interactive signaling network which establishes the
level of expression of the different regulatory components of the
pathway, or if additional signaling pathways regulate their
expression.
The regulation of BMP modulators was studied in 2 days old
Micromass cultures after 6 hr treatments with the signaling
molecules that are responsible for growth and differentiation of
the autopod mesoderm, including the following: FGFs which are
implicated initially in the maintenance of the undifferentiated state
of the mesoderm in the distal margin of the bud and in inhibiting
the chondrogenic differentiation of digit progenitors [14], and they
are involved later in tendon differentiation [55]; all-trans-Retinoic
Acid which, similar to FGF signaling, is a primary inhibitor of
mesodermal differentiation [56] and later regulates the differen-
tiation of tendons [57]; ACTIVIN A, which is an early signal for
the formation of digit chondrogenic aggregates and next a
prominent joint marker [40]; TGF bs, which are responsible for
the formation of tendons but also promote the formation of
prechondrogenic aggregates [58,59]; BMP2, which together with
other BMPs are responsible for cartilage differentiation [8]; and
WNT 5a, which together with other members of the family are
involved in cartilage and joint differentiation [60].
The following data can be stressed from our results (Table 5):
1) In the FGF treated cultures, the expression of BMP
modulators including Noggin, Chordins and Fstl-1 was
inhibited. The inhibition was also strong for Dan and Tll1.
In contrast, BMPER, Fstl-5, and Sost were highly upregulated
by FGF treatments. Other antagonists (Sostdc1, Fst, and Tsg)
were not regulated at significant levels by FGFs.
2) Consistent with the functional similarity between retinoic
acid and FGF signaling in cartilage and tendon differenti-
ation at the stages studied here, the addition of all-trans-
Retinoic Acid (RA) to the culture medium was followed by a
downregulation of Noggin, Chordins, Tll1 and Dan. In contrast
with findings obtained by FGF treatments, Sostdc1 was the
only antagonist upregulated by RA. The expression of the
remaining studied antagonists was not modified by RA
treatments.
3) Treatments with ACTIVIN A resulted in a strong
upregulation of Fst expression. There was also an increase
in the expression of the BMP modulators Noggin, Chordins,
Tsg and Fstl-1. In contrast the BMP modulators that are
expressed in or around the tendon blastemas, including Dan,
and BMPER were downregulated.
4) Tgfb1 treatments upregulated Noggin, Sostdc1 and Fst while
Chordins, Tll1 and BMPER were downregulated. The
expression levels of the other studied antagonists were not
modified.
5) BMP2 treatments induced a strong up-regulation of Noggin,
Chdl-1, and Fst while all the remaining antagonists were
downregulated. It is remarkable from these findings that
BMP2 was the only treatment which downregulated the
expression of Tsg
6) WNT5a treatments induced up-regulation of BMPER and
Sost. Expression of other BMP modulators was not modified.
Discussion
We show that 9 representatives of the three recognized
subfamilies of BMP antagonists [61] together with Tll1, Fst, Fstl-
1 and Fstl-5 are expressed in a regulated fashion during the early
histogenesis of the digit tissues. These factors are precociously
induced during the formation of an extra digit, preceding the
appearance of changes identifiable by conventional histological
procedures, such as the establishment of phalanges, joints and
tendons. These findings support the role of BMP modulators in
digit morphogenesis. However, except for Noggin [4], Fstl-1 [42],
and Sost [62], mice with genetic alterations in these factors,
including BMPER [63], Tsg [63,64], Chd [65], Dan [38], Fst [66],
Sostdc1 [67], and Tll1 [68] lack a digit phenotype. The lack of a
phenotype in these mutants is likely explained by functional
redundancy [42,69]. In line with this interpretation, we show
overlapping expression of Noggin/Chdl-1 in the developing
cartilage, Chdl-2/Fstl-1 in the developing joints, Tsg/Dan/Fst in
the tendon blastemas, BMPER/Sostdc1/Fstl-1 in the peritendinous
mesenchyme, and Chd/Chdl-2/Fstl-5/BMPER/Sost under the
perichondrium of the diaphysis that is undergoing hypertrophic
differentiation and subsequent ossification.
The functional properties of the different BMP antagonists often
includes crosstalk or the inhibition of other signaling pathways
which results in tissue- and developmental-context dependent
responses to their local administration [70,71]. Consistent with the
occurrence of functional specializations, the analyzed antagonists
downregulated the expression of BMP target genes during
skeletogenesis at different levels and their expression was
differentially controlled by the distinct signaling pathways acting
in the developing limb at the stages covered by this study (see
Table 5). Together these findings favor the view considering that
morpho-histogenesis of cartilage/bone, joints, and tendons in the
embryonic limb is generated by a cascade of autoactivation and
lateral inhibition signals resulting from local interactions of
mesenchymal progenitors (‘‘reactor–diffusion’’ model, see
[72,73], and references therein). The formation of the prechon-
drogenic aggregate constitutes the first step of this process and is
followed not only by the inhibition of chondrogenesis in the
adjacent tissue, but also by signals which regulate its divergent
differentiation to form joints and tendons.
Considering the pattern of expression in the autopod (Table 6),
the different BMP modulators can be grouped as follows: 1)
cartilage associated, which include: Noggin, Chdl-1, and Fstl-5; 2)
joint associated, represented by Chdl-2 and Fstl-1, although the
later is also expressed in the undifferentiated interdigital mesen-
chyme, and Noggin is expressed in the cartilage encompassing the
developing joints; 3) tendon or associated peridigital connective
tissue, which include the following: Dan, BMPER, Sost, Sostdc1, Fst,
and at stages of advanced differentiation, also Noggin, and Fstl-5;
and, 4) a group which can be termed ‘‘mixed distributed’’, is
represented by Tsg, Tll1, and Chd which may function in concert
with the other antagonists.
TSG, Chd, and Tll1 and the Differentiation of Cartilage
and Tendons
Due to their association with other BMP modulators in
developing cartilage, joints and tendons, the functional signifi-
cance of TSG, CHD, and TLL1, merits individual discussion.
TSG is a multifunctional BMP modulator, which interacts with
other antagonists to potentiate or inhibit their function depending
on the proteolytic activity of TLL1 (reviewed in [74]). TSG forms
heterotrimeric complexes with BMPs and CHD which potentiates
the antagonistic effect of CHD and facilitates the diffusion of BMP
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ligands through the extracellular space to reach the appropriate
targets [28,75]. In addition, when the complex is subjected to the
action of TOLLOID metalloprotease, CHD is cleaved, delivering
active BMPs [76]. TSG also forms trimolecular complexes with
BMPER and BMP4 [69] but in this case the complex does not
promote BMP diffusion [26].
We show that the contour of the phalanges at the stages of initial
differentiation express Tsg, Tll1 and Chd. Taking into account that
BMP ligands are predominantly expressed outside the cartilage
rods in the undifferentiated interdigital mesoderm [3], this
expression pattern is consistent with a function of the complex
TSG/CHD in the transport and subsequent delivery of BMPs into
the differentiating cartilages, which are positive for phospho Smad
1/5/8 immunolabeling. In our culture model, the overexpression
of Tsg down-regulates markers that are activated by BMPs. In
addition, consistent with previous studies [64,77,78], we also noted
the occurrence of pro-BMP responses, such as the intense down-
regulation of Gdf5, which is an effect that is also induced by BMP2
treatments.
The distribution of ‘‘mixed distributed’’ BMP modulators in the
zones of tendon formation is more complex. We show that the
core of the tendon blastemas expresses high levels of Tsg
accompanied, in a stage-dependent manner, with other BMP
antagonists (see discussion below). Remarkably, at initial stages of
formation, the tendon blastemas lack Tll1 transcripts, suggesting
that in this tissue TSG exerts only an anti-BMP function. This
interpretation is consistent with the poor labeling of the tendon
blastemas with phospho Smad 1/5/8. Taking into account that
overexpression of TSG in mesoderm progenitor cultures results in
the inhibition of chondrogenic markers without a positive
influence on tendon markers, the expression of Tsg could preclude
chondrogenic differentiation of the pretendinous mesenchymal
aggregates, which is the default fate of the undifferentiated limb
mesoderm. Mice deficient in TSG lack a digit or tendon
phenotype [64], but this could be explained by the overlapping
expression of additional antagonists (see below).
During the differentiation of the tendon blastemas, in the
subectodermal mesenchyme of the proximal region of the
interdigit intercalated between two neighbor tendons, there are
intense expression domains of Tll1 overlapping with low levels of
Tsg and high levels of BMPER. This gene expression pattern
correlates with strong immunolabeling for phospho Smad 1/5/8,
suggesting that the presence of TOLLOID reverses the influence
of TGS on BMP signaling from negative to positive. Furthermore,
the negative regulation of Tll1 by FGFs, TGF bs, and RA which
are all key signals in the differentiation of tendons [55,57–59]
reinforces the idea that TSG functions in the initial differentiation
of the tendon blastemas requires the absence of TOLLOID. At
more advanced stages of differentiation and coinciding with the
Table 5. Regulation of BMP modulators.
FGF2 RA Activin A TGFb1 BMP2 Wnt5a
Noggin 0,4060,0* 0,5160,0*** 2,1560,3* 1,7660,2* 33,8662,5** 1,1460,1
Chordin 0,7260,0 0,1260,0*** 1,3560,2 0,5960,0* 0,1760,0*** 0,9660,1
Chdl-1 0,1260,0** 0,6660,0** 2,2960,3* 0,5260,0* 3,7560,1*** 1,2160,2
Chdl-2 0,0560,0*** 0,0160,0** 1,9060,1** 0,6760,0 0,6560,2 0,9860,0
Tsg 1,3560,1 1,0460,0 2,0960,1* 0,9160,0 0,5360,0*** 1,2460,1
Dan 0,1560,0** 0,5460,0** 0,4660,0* 0,8360,0 0,1460,0*** 1,0960,3
Sost 2,6460,4* 0,8060,0 0,6360,2 0,9260,1 0,3860,0* 1,9860,1*
Sostdc1 0,8860,0 2,6660,3** 1,1860,2 3,4060,2* 0,5060,0*** 1,0260,2
Follistatin 0,9860,0 0,8160,0 9,0660,7** 4,9560,6* 7,4860,8** 1,0460,1
Fstl-1 0,3360,0*** 0,9060,0 1,5660,0* 1,1860,3 0,4560,0* 0,8060,0
Fstl-5 2,3760,2* 0,8360,0 0,7560,1 0,9460,2 0,6660,1 1,0960,2
Tll1 0,2160,0** 0,2660,0** 0,7360,0 0,4760,0* 0,2160,0*** 0,8660,0
Bmper 8,2960,3** 0,9060,1 0,3260,0* 0,4060,0* 0,3460,0** 4,5760,1***





Table 6. Semi-quantitative association of gene expression






Noggin +++ – – + –
Chordin + ++ – + –
Chdl-1 +++ – – – –
Chdl-2 – +++ – – –
Tsg + ++ +++ + +
Dan – – +++ ++ ++
Bmper – – – – +++
Sost – – – ++ –
Sostdc1 – – – – ++
Follistatin – – +++ ++ –
Fstl-1 – ++ + + ++
Fstl-5 + – – +++ –
Tll1 + ++ – + ++
Table summarizing the expression intensity of the BMP modulators in the
autopodial tissues.
doi:10.1371/journal.pone.0060423.t006
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appearance of Tll1 transcripts, immunolabeling for phospho-Smad
1/5/8 becomes visible in the tendon primordia.
BMP Antagonists and the Formation of Phalanges and
Joints
Digits develop as cartilage rods, which become segmented into
jointed structures by local de-differentiation of cartilage. Hence,
the zones of joint formation appear as strips of fibrous-like
connective tissue, which constitute the substrate for subsequent
cavitation and differentiation of the joint tissues (fibrous capsule
and synovium). It has been shown that Jaws exerts a central role in
the formation of joints, although lack specific expression domains
in these regions [45]. The formation of phalanges is a direct effect
of BMP signaling via Smad 1/5/8 [48]. Differentiation of the
joints is also controlled by BMP signaling [5,79], but it is directed
by the activation of MAP kinases [22]. Furthermore, the reduced
phalangeal size and loss of interphalangeal joints that is observed
in humans and mice deficient in NOGGIN [4,17], indicates that
regulation of BMP signaling is a central function in the formation
of phalanges and joints.
Our findings reveal that the outer layer of the developing
phalanges expressing Tsg/Tll1/Chd encompass a core of differen-
tiating chondrocytes expressing Chdl-1 and Noggin in the body of
the phalanx, and Chdl-2 in the zones of joint formation. We show
that CHDL1 alone, or even in combination with TSG, does not
modify proliferation, at difference of studies in other systems [53].
The effect of NOGGIN and both CHDL-1 and CHDL-2 on
cultures of digit progenitors, concerns tissue differentiation, and
becomes intensely potentiated by TSG. Together these findings
suggest that, in addition to the previously discussed role of TSG/
CHD complexes in the transport of BMP ligands, TSG also
functions in a concerted fashion with NOGGIN and CHORDINS
to modulate the intensity of BMP signaling in the differentiating
cartilage.
We further show that cartilage-expressed (Noggin and Chdl-1)
and joint-expressed antagonists (Chdl-2 and Fstl-1) are regulated in
an opposite fashion by BMP2. The positive regulation of Noggin
and Chdl-1 by BMP2 is consistent with the occurrence of a
negative feed-back loop tuning the level of BMP signaling in the
differentiating cartilage as observed in different systems [80].
Conversely, the negative regulation of Chdl-2 by BMP2, suggest
that joints are formed in zones of the digit cartilage templates with
the lowest BMP signal.
BMP Antagonists and the Establishment of Tendons and
Intertendinous Mesoderm
Tendon blastemas are formed in the mesoderm subjacent to the
dorsal or ventral ectoderm. We have previous shown that all the
subectodermal tissue of the autopod has the potential to
differentiate into tendons, but that in normal conditions, tendons
differentiated only in the digit regions [40,81]. The present study
shows a regionalization of the mesoderm subjacent to the
ectoderm into digit and interdigit regions characterized by distinct
distribution of BMP antagonists accompanied, at the beginning of
tendon formation, by differences in Smad 1/5/8 phosphorylation.
Tendon blastemas are formed in zones expressing high levels of
Dan, Fst, and Tsg, which recruit Chd, Noggin and Sost at advanced
stages of differentiation. During the differentiation of these tendon-
forming regions, the subectodermal mesenchyme intercalated
between the tendon blastemas shows intense domains of BMPER
expression accompanied by reduced expression of Dan, TSG, Tll1,
and Sostdc1. As mentioned above, the different patterns of gene
expressions correlate with a dramatic change in the intensity of
BMP signaling. This finding might be of interest in regenerative
medicine to direct the differentiation of connective tissue
progenitors. However, there is no tendon phenotype in mice
deficient for these factors [38,63,66,67]. The difference in the
intensity of phospho Smad 1/5/8 immunolabeling might be due
to the antichondrogenic and profibrogenic action of DAN in
conjunction with and the functional interplay between BMPER
with TSG and TLL1. BMPER has been characterized as a CHD
related BMP modulator with context-dependent pro-BMP or anti-
BMP activities [63,69,82–84]. Our findings show that its
expression marks zones of very high BMP activity. In previous
studies the expression of BMPER in the autopod has been
functionally related with interdigital cell death [33]. However, the
spatial distribution of BMPER transcripts and their maintenance
after the period of interdigital cell death, support the involvement
of this BMP modulator in the formation of the peridigital
connective tissues.
Conclusion
In conclusion our findings reinforce the morphogenetic
importance of BMP antagonists in the establishment of a
molecular signaling scaffold that is responsible for the allocation
of the cell fate of digit mesodermal progenitors. The information
drawn from this study provides a basic view of this functional
signaling network but further work is required to unravel the
exquisite extracellular regulation of BMP signaling during the
histotypic differentiation of digit precursor mesoderm. A subject to
be addressed in future studies is that the function of the different
BMP modulators in tendon development may result from a
combination BMP and Wnt modulation, as several factors such as
Sost [34,85], Noggin [86], Chd [87], and Sostdc1 [85,88], have
been shown to exert both functions.
Supporting Information
Figure S1 Representative flow cytometry plots of disso-
ciated mesodermal cells propidium iodide stained,
obtained from 2 day Micromass in control (A and B),
CHDL-1 treated (A9 and B9), and CHDL-1 plus TSG
treated cultures of digit progenitors. Upper panels (A–A0)
represent the cell cycle distribution of cells expressed in a linear
scale. In lower panels (B–B0) the intensity of propidium iodide
label is plotted on a logarithmic scale to show the presence of cell
death (sub-G1 region). The percentage of dying cells is indicated.
(TIF)
Table S1 Primers for Q-PCR. Note that except indicated,
the primers are for Gallus gallus.
(DOC)
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